{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:43:50Z","timestamp":1759365830278,"version":"build-2065373602"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.humimm.2019.12.004","type":"journal-article","created":{"date-parts":[[2019,12,14]],"date-time":"2019-12-14T07:40:50Z","timestamp":1576309250000},"page":"162-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Expression of membrane-bound human leucocyte antigen-G in systemic sclerosis and systemic lupus erythematosus"],"prefix":"10.1016","volume":"81","author":[{"given":"Simone","family":"Negrini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Contini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Pupo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Greco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Murdaca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Puppo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2019.12.004_b0005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-0897.2004.00208.x","article-title":"HLA-G expression in placenta in relation to HLA-G genotype and polymorphisms","volume":"52","author":"Hviid","year":"2004","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.humimm.2019.12.004_b0010","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4049\/jimmunol.144.2.731","article-title":"Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule","volume":"144","author":"Ellis","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2019.12.004_b0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1084\/jem.186.2.289","article-title":"Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts","volume":"186","author":"Crisa","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2019.12.004_b0020","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.humimm.2003.08.346","article-title":"Expression of HLA-G in human cornea, an immune-privileged tissue","volume":"64","author":"Le Discorde","year":"2003","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2019.12.004_b0025","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/db05-0731","article-title":"The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G","volume":"55","author":"Cirulli","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.humimm.2019.12.004_b0030","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1600-6143.2009.02650.x","article-title":"Immunohistochemical study of HLA-G expression in lung transplant recipients","volume":"9","author":"Brugiere","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2019.12.004_b0035","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1182\/blood-2004-03-0809","article-title":"Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis","volume":"104","author":"Menier","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2019.12.004_b0040","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1182\/blood-2007-12-127662","article-title":"Beyond the increasing complexity of the immunomodulatory HLA-G molecule","volume":"111","author":"Carosella","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2019.12.004_b0045","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00018-010-0584-3","article-title":"Emerging topics and new perspectives on HLA-G","volume":"68","author":"Fainardi","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.humimm.2019.12.004_b0050","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.imlet.2011.02.011","article-title":"The tolerogenic molecule HLA-G","volume":"138","author":"Carosella","year":"2011","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.humimm.2019.12.004_b0055","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/10408363.2012.677947","article-title":"The immunosuppressive molecule HLA-G and its clinical implications","volume":"49","author":"Gonzalez","year":"2012","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"10.1016\/j.humimm.2019.12.004_b0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.ai.2015.04.001","article-title":"HLA-G: an immune checkpoint molecule","volume":"127","author":"Carosella","year":"2015","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.humimm.2019.12.004_b0065","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2006-05-024547","article-title":"Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells","volume":"109","author":"LeMaoult","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2019.12.004_b0070","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1182\/blood-2006-11-057125","article-title":"HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation","volume":"110","author":"Feger","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2019.12.004_b0075","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1182\/blood-2011-07-370742","article-title":"The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells","volume":"118","author":"Carosella","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2019.12.004_b0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ana.21705","article-title":"Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis","volume":"66","author":"Huang","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.humimm.2019.12.004_b0085","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.humimm.2019.12.004_b0090","doi-asserted-by":"crossref","DOI":"10.1007\/s10238-019-00553-y","article-title":"Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study","author":"Negrini","year":"2019","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.humimm.2019.12.004_b0095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fimmu.2017.00018","article-title":"Phenotypic Alterations Involved in CD8+ Treg Impairment in Systemic Sclerosis","volume":"8","author":"Negrini","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2019.12.004_b0100","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","article-title":"Pathogenesis of Systemic Sclerosis","volume":"6","author":"Pattanaik","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2019.12.004_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2014.08.001","article-title":"Pathophysiology of systemic sclerosis: state of the art in 2014","volume":"43","author":"Dumoitier","year":"2014","journal-title":"Presse Med."},{"key":"10.1016\/j.humimm.2019.12.004_b0110","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.molimm.2004.06.025","article-title":"Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis","volume":"41","author":"Sato","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.humimm.2019.12.004_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/039463200702000101","article-title":"BAFF and rheumatic autoimmune disorders: implications for disease management and therapy","volume":"20","author":"Bosello","year":"2007","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.humimm.2019.12.004_b0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11926-011-0215-5","article-title":"Dendritic cells: novel players in fibrosis and scleroderma","volume":"14","author":"Lu","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.humimm.2019.12.004_b0125","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.autrev.2012.05.004","article-title":"Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases","volume":"12","author":"Fenoglio","year":"2012","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.humimm.2019.12.004_b0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.clim.2011.01.013","article-title":"Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis","volume":"139","author":"Fenoglio","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.humimm.2019.12.004_b0135","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/03009742.2010.528021","article-title":"Altered T-cell and regulatory cell repertoire in patients with diffuse cutaneous systemic sclerosis","volume":"40","author":"Papp","year":"2011","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.humimm.2019.12.004_b0140","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3899\/jrheum.080552","article-title":"HLA-G expression in the skin of patients with systemic sclerosis","volume":"36","author":"Wastowski","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.humimm.2019.12.004_b0145","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus","volume":"358","author":"Rahman","year":"2008","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.humimm.2019.12.004_b0150","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaut.2006.06.005","article-title":"Regulatory T cells in patients with systemic lupus erythematosus","volume":"27","author":"Alvarado-Sanchez","year":"2006","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.humimm.2019.12.004_b0155","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.autrev.2004.07.035","article-title":"Dysfunctional B cells in systemic lupus erythematosus","volume":"3","author":"Renaudineau","year":"2004","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.humimm.2019.12.004_b0160","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/08830180490452594","article-title":"Altered expression of the T cell receptor-CD3 complex in systemic lupus erythematosus","volume":"23","author":"Takeuchi","year":"2004","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.humimm.2019.12.004_b0165","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ni0901-764","article-title":"Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity","volume":"2","author":"Lipsky","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2019.12.004_b0170","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10238-016-0430-5","article-title":"The antiphospholipid syndrome: from pathophysiology to treatment","volume":"17","author":"Negrini","year":"2017","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.humimm.2019.12.004_b0175","first-page":"24","article-title":"Association between a Functional HLA-G 14-bp Insertion\/deletion Polymorphism and Susceptibility to Autoimmune Diseases: A Meta-analysis","volume":"61","author":"Lee","year":"2015","journal-title":"Cell. Mol. Biol. (Noisy-le-grand)"},{"key":"10.1016\/j.humimm.2019.12.004_b0180","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/tan.12545","article-title":"Comprehensive analysis of polymorphisms in the HLA-G 5' upstream regulatory and 3' untranslated regions in Brazilian patients with systemic lupus erythematosus","volume":"85","author":"Catamo","year":"2015","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2019.12.004_b0185","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.humimm.2012.11.024","article-title":"HLA-G may predict the disease course in patients with early rheumatoid arthritis","volume":"74","author":"Rizzo","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2019.12.004_b0190","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1399-0039.2008.01037.x","article-title":"HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus","volume":"71","author":"Rizzo","year":"2008","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2019.12.004_b0195","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0197-4580(93)90053-E","article-title":"Age-related behavioral impairments: benefits of multiple measures of performance","volume":"14","author":"Olton","year":"1993","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.humimm.2019.12.004_b0200","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10875-010-9496-0","article-title":"Expression and functional role of HLA-G in immune cells from patients with systemic lupus erythematosus","volume":"31","author":"Monsivais-Urenda","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.humimm.2019.12.004_b0205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humimm.2007.11.001","article-title":"Expression of human leukocyte antigen-G in systemic lupus erythematosus","volume":"69","author":"Rosado","year":"2008","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2019.12.004_b0210","first-page":"463","article-title":"Tripterygium wilfordii in the treatment of the nephritis of anaphylactoid purpura","volume":"9","author":"Pan","year":"1987","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"key":"10.1016\/j.humimm.2019.12.004_b0215","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/cei.13134","article-title":"Evaluation of membrane-bound and soluble forms of human leucocyte antigen-G in systemic sclerosis","volume":"193","author":"Contini","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2019.12.004_b0220","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.humimm.2019.12.004_b0225","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.humimm.2019.12.004_b0230","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.humimm.2019.12.004_b0235","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.4049\/jimmunol.156.11.4224","article-title":"Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma","volume":"156","author":"Yang","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2019.12.004_b0240","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.humimm.2016.01.016","article-title":"CD4(+)HLA-G(+) regulatory T cells: Molecular signature and pathophysiological relevance","volume":"77","author":"Pankratz","year":"2016","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2019.12.004_b0245","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1096\/fj.14-251074","article-title":"Human CD4+ HLA-G+ regulatory T cells are potent suppressors of graft-versus-host disease in vivo","volume":"28","author":"Pankratz","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.humimm.2019.12.004_b0250","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1189\/jlb.1RU0814-382","article-title":"CD4+\/CD8+ double-positive T cells: more than just a developmental stage?","volume":"97","author":"Overgaard","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.humimm.2019.12.004_b0255","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1002\/art.22927","article-title":"Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis","volume":"56","author":"Parel","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.humimm.2019.12.004_b0260","first-page":"513","article-title":"Double positive CD4+CD8+ T cells: key suppressive role in the production of autoantibodies in systemic lupus erythematosus","volume":"140","author":"Wu","year":"2014","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.humimm.2019.12.004_b0265","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.4049\/jimmunol.1300438","article-title":"Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses","volume":"192","author":"Naji","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2019.12.004_b0270","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1073\/pnas.201407398","article-title":"Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism","volume":"98","author":"Lila","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.humimm.2019.12.004_b0275","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.4049\/jimmunol.164.12.6100","article-title":"Cutting edge: soluble HLA-G1 triggers CD95\/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8","volume":"164","author":"Fournel","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2019.12.004_b0280","doi-asserted-by":"crossref","first-page":"11520","DOI":"10.1073\/pnas.94.21.11520","article-title":"Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis","volume":"94","author":"Rouas-Freiss","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885919313023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885919313023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:52:48Z","timestamp":1759319568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885919313023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0198885919313023"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2019.12.004","relation":{},"ISSN":["0198-8859"],"issn-type":[{"type":"print","value":"0198-8859"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of membrane-bound human leucocyte antigen-G in systemic sclerosis and systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2019.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}]}}